Sinopharm

Sinopharm Group Company Limited
国药控股股份有限公司
State-owned enterprise (Red chip)
Industry Pharmaceutical
Founded 2003
Headquarters Beijing, People's Republic of China
Key people
 Mr. She Lulin (Chairman)
Parent China National Pharmaceutical Group Corporation
Website Sinopharm Group Company Limited

Sinopharm Group Company Limited (SEHK: 01099) is the largest pharmaceutical company in China, jointly owned by China National Pharmaceutical Group Corporation and Shanghai Fosun Pharmaceutical. Its revenue in 2015 reached 227 billion RMB ($35 billion USD).[1][2]

Sinopharm Group researches and develops, manufactures, distributes, and markets medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. It also has 10 subsidiaries and a number of major joint ventures. The company also runs about a dozen retail pharmacy chains. Sinopharm Group, which has operations in Africa, France, Germany, Hong Kong, the US, and Vietnam, was formed in 1998.

Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share.

See also

References

  1. ↑ http://finance1.jrj.com.cn/news/2008-06-07/000003735074_001.html 国药再谋医药重组央企一哥
  2. ↑ China's Sinopharm gets OK for $1 bln HK IPO

External links

This article is issued from Wikipedia - version of the Saturday, April 30, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.